08:06:35India

CareDx, Inc. (CDNA)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
379,805,000 13.8%
Net income
-21,354,000 -140.6%
Operating income
-30,781,000
Earnings per share
-0.40 -140%
R&D expense
71,429,000

Growth and profitability

Operating margin
-8.10
Net margin
-5.62
Return on equity
-7.05
Return on assets
-5.17

Balance sheet

Total assets
413,228,000
Total liabilities
110,127,000
Shareholders' equity
303,101,000
Cash and equivalents
65,429,000
Current ratio
2.86

Cash flow and ratios

Operating cash flow
42,032,000

Shareholder returns

Share buybacks
87,768,000
Shares outstanding
52,542,786
Book value per share
5.77
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Brisbane, CA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Services-Medical Laboratories

Fiscal year end: · Source: SEC EDGAR

CareDx, Inc. trades on NASDAQ under the ticker symbol CDNA. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis